Ukraine war: After Russia suffered setbacks last month, Putin was reportedly seeking a peace deal with Ukraine but now has told his people involved in bid to end the war that he sees no prospect for a settlement.
Russian president Vladimir Putin has lost interest in diplomatic efforts to end the Ukraine war and seems to now be set on seizing as much territory as possible, news website Financial Times reported.
After Russia suffered setbacks last month, Putin was reportedly seeking a peace deal with Ukraine but now has told his people involved in bid to end the war that he sees no prospect for a settlement.
“Putin sincerely believes in the nonsense he hears on [Russian] television and he wants to win big,” a person briefed on the talks Putin had with his officials, told the website. The talks stalled after Ukrainian president Volodymyr Zelensky accused Russia of committing war crimes against civilians in Bucha and Mariupol.
The Russian president was furious after Ukraine sank the Moskva, the flagship of Moscow’s Black Sea fleet, and said the peace efforts were at a dead end.
Russia on Friday had announced that one crew member had died and 27 were missing after the missile cruiser had sunk.
“As a result of a fire on April 13, the Moskva missile cruiser was seriously damaged due to the detonation of ammunition,” the defence ministry had said in a statement. However, Pentagon claimed that the Russian warship had sunk in the Black Sea after being hit by two missiles from Ukraine.
The fighting between the two forces has entered the third month. The United Nations commission on refugees has estimated nearly five million people have fled Ukraine since Moscow’s all out invasion on the eastern European country on February 24.
US Secretary of State Antony Blinken and defence secretary held talks with the Ukrainian president in Kyiv last Sunday. Zelensky is said to have asked the United States for more powerful weapons to resist the Russian offensive in the south and east, Reuters reported.
Clashes between radicals and law enforcement officers erupted in Paris after the announcement of preliminary presidential election results, with police having used tear gas against the demonstrators, a Sputnik correspondent reports. The French presidential election runoff was held on Sunday. According to a Sputnik correspondent, young people started gathering in the Place de la Republique in the French capital after the preliminary results were announced. Slogans were heard both against Incumbent President Emmanuel Macron and far-right presidential candidate Marine Le Pen.
Marine Le Pen – unbowed bLe Pen’ser third failed bid for the presidency – on Sunday promised her supporters that she will keep up the fight in the June parliamentary elections. “I will continue the fight for France and the French people,” Le Pen said in a defiant speech. Here’s what Le Pen stood for in her presidential campaign 1.
Over the course five-year course as France’s president, Emmanuel Macron has gone from a young newbie in politics to a key world player and weighty decision-maker in the European Union. In 2017, He beat far-right candidate Marine Le Pen in their runoff that year on promises to free up France’s economy to boost job creation and attract foreign investment. He beat her again Sunday, but the race was closer this time.
Deposed Myanmar leader Aung San Suu Kyi faces a possible 15 years in prison on Monday, when a court in the military-ruled country is scheduled to deliver a verdict in the first of multiple corruption cases against her. Suu Kyi, 76, is being held in an undisclosed location, without visitors. The military has restricted information about her trial and imposed a gag order on her lawyers. The international community calls the trial a farce.
An experimental treatment from Shionogi & Co Ltd has shown rapid clearance of the virus that causes COVID-19, according to new data, the Japanese drug maker said on Sunday. The pill, S-217622, “demonstrated rapid clearance of the infectious SARS-CoV-2 virus”, Shionogi said in a statement, citing Phase-2b results from the Phase II/III clinical trial of the drug. Shionogi’s shares have been on a rollercoaster on speculation about success of the treatment.